Introduction
As EU MDR enforcement tightens and global regulatory bodies raise clinical evidence standards, medical device manufacturers face mounting compliance pressure. A poorly written Clinical Evaluation Report (CER) can stall or derail market entry entirely—recent surveys of EU notified bodies show that approximately 11% of device applications are not approved, with clinical evidence gaps among the most cited reasons.
That compliance pressure makes vendor selection just as consequential as the report itself. With dozens of CER writing service providers competing for your business, the wrong partner means costly resubmissions, notified body queries, and delays that can push your product launch back by months.
This article presents a curated list of the top 10 CER writing services for 2026, explains what to look for in a provider, and gives you a clear framework for matching the right firm to your device class and target regulatory markets.
TL;DR
- A CER synthesizes clinical evidence to demonstrate device safety and performance—mandatory for EU, UK, Australia, Canada, and other key markets
- Look for services that cover regulatory expertise, scientific writing, and post-submission support — not document production alone
- Avoid selecting based on price alone; prioritize transparent timelines, proven credentials, and multi-regulatory coverage
- Each provider here was evaluated on regulatory track record, global reach, device versatility, and compliance outcomes
What Is CER Writing and Why Does It Matter in 2026?
A Clinical Evaluation Report (CER) is a systematic, documented evaluation of clinical data (published literature, post-market surveillance, and clinical investigations) that demonstrates a device's safety and performance to regulators. Required under EU MDR Annex XIV and MEDDEV 2.7/1 rev 4, the CER is now referenced by FDA and other global bodies — making it a non-negotiable step for manufacturers pursuing international market access.
Why 2026 is particularly critical:
- EUDAMED mandatory modules go live: Four EUDAMED modules become mandatory on 28 May 2026, including device registration and notified body certificates
- MDR transition deadlines tighten: Regulation (EU) 2023/607 extends legacy device deadlines only until 31 December 2027 (Class III) and 31 December 2028 (lower classes)—under strict conditions
- Notified body capacity remains constrained: NB backlogs continue, and clinical evidence deficiencies are among the top reasons for certificate refusals or delays
With notified body timelines already stretched and regulators scrutinizing clinical evidence more closely, most manufacturers — from startups to global OEMs — are turning to specialized CER writing services to avoid costly delays.
Top 10 CER Writing Services for Medical Devices in 2026
Selection note: These providers were evaluated on regulatory expertise, global framework coverage, device type versatility, client track record, and quality of post-submission support—not on marketing claims.
Elexes
Elexes is a global medical device regulatory consulting firm with 50+ years of collective experience, serving 100+ clients across the USA, EU, UK, Canada, Australia, and Asia across 200+ product types—offering end-to-end CER writing as part of its full regulatory consulting suite.
Its multi-regulatory coverage spans EU MDR, FDA, Health Canada, EMA, MHRA, and HSA under one roof. A 90% audit clearance rate and the ability to pair CER writing with post-market surveillance, PMCF, and QMS services make it a full lifecycle compliance partner—not just a document vendor.
| Attribute | Details |
|---|---|
| Key Services | CER/CEP writing, systematic literature review, PMCF planning, post-market surveillance, regulatory strategy, QMS support |
| Regulatory Frameworks Covered | EU MDR, FDA, Health Canada, EMA, MHRA, HSA, ISO 13485, ISO 14971 |
| Notable Strength | End-to-end lifecycle support; 90% audit clearance rate; flexible engagement models (full-time, part-time, project-based) |
Mantra Systems
Mantra Systems is a UK-based regulatory consulting firm focused exclusively on EU MDR and IVDR compliance, offering dedicated CEP and CER writing services alongside QMS and SaMD regulatory support.
Its clinical evaluation service is a standalone practice, not a bolt-on offering. Fixed pricing, fixed timelines, and free post-submission notified body query support address the most common outsourcing frustrations directly.
| Attribute | Details |
|---|---|
| Key Services | CER/CEP writing, EU MDR consulting, IVDR consulting, SaMD regulatory support |
| Regulatory Frameworks Covered | EU MDR, UK MDR, IVDR |
| Notable Strength | Dedicated CER/CEP focus; fixed-price model; free post-submission NB query support |
Celegence
Celegence is a global life sciences regulatory consultancy offering CER writing supported by its proprietary AI platform (CAPTIS®), claiming MDR-compliant CER delivery in as few as 6 weeks—with in-house SMEs including physicians, PhDs, engineers, and regulatory experts.
The CAPTIS® platform automates literature review and document drafting, cutting manual effort and compressing timelines. This sits alongside a full MDR/IVDR portfolio covering PMCF, PMS, and systematic literature reviews.
| Attribute | Details |
|---|---|
| Key Services | CER/CEP writing, SLR, PMCF, PMS, IVDR consulting, AI-assisted regulatory writing (CAPTIS®) |
| Regulatory Frameworks Covered | EU MDR, EU IVDR, US FDA |
| Notable Strength | AI-enabled CER delivery in ~6 weeks; large in-house SME pool; AI-assisted document workflows |
MED Institute
MED Institute is a US-based contract research and development organization (CRO) offering scientific communications services—including CER writing—alongside medical device testing, engineering, and clinical trial management.
CER writing integrates directly with in-house preclinical testing, clinical trial data, and device engineering within a single engagement. This is particularly useful for manufacturers whose CER needs to be grounded in first-party clinical evidence rather than literature alone.
| Attribute | Details |
|---|---|
| Key Services | CER writing, clinical evaluation, scientific communications, clinical trial management, regulatory submissions |
| Regulatory Frameworks Covered | EU MDR, US FDA |
| Notable Strength | CER writing integrated with in-house clinical and preclinical data generation; strong scientific foundation from combined CRO capabilities |
Emergo by UL
Emergo by UL is a global medical device regulatory consulting firm operating in 40+ countries, offering CER writing as part of a comprehensive EU MDR compliance and global market access portfolio.
Its large team of regional experts supports multi-market submissions simultaneously, with regulatory intelligence spanning 40+ countries. Large OEMs and multinational device manufacturers with complex portfolios are its natural fit.
| Attribute | Details |
|---|---|
| Key Services | CER writing, EU MDR consulting, global market access, regulatory strategy, QMS auditing |
| Regulatory Frameworks Covered | EU MDR, FDA, Health Canada, TGA, PMDA, and others |
| Notable Strength | Global presence in 40+ countries; multi-market submission coordination; suited for large portfolios |
NAMSA
NAMSA is a medical device-focused CRO offering regulatory writing services including CER development, alongside biocompatibility testing, clinical research, and regulatory submissions across multiple global markets.
The combination of an in-house testing laboratory and regulatory writing team means manufacturers can generate, interpret, and document clinical and biocompatibility data within a single CRO relationship—reducing handoff risk between data generation and documentation.
| Attribute | Details |
|---|---|
| Key Services | CER writing, biocompatibility testing, clinical research, regulatory submissions, PMS |
| Regulatory Frameworks Covered | EU MDR, US FDA, ISO 10993, ISO 14971 |
| Notable Strength | Integrated testing + regulatory writing; strong biocompatibility and clinical data pipeline for CERs |
Freyr Solutions
Freyr Solutions is a global regulatory solutions firm providing CER writing and regulatory documentation services for medical devices, with a technology-enabled platform supporting multi-market submissions across the EU, US, and APAC regions.
Standardized documentation workflows sit at the center of its model, reducing errors and compressing notified body review cycles. The platform supports multi-market dossier management, which scales well for manufacturers with broad regional submission needs.
| Attribute | Details |
|---|---|
| Key Services | CER writing, EU MDR/IVDR documentation, regulatory strategy, dossier management, eCTD publishing |
| Regulatory Frameworks Covered | EU MDR, EU IVDR, US FDA, TGA, Health Canada |
| Notable Strength | Technology-enabled regulatory workflows; multi-market documentation support; scalable for large portfolios |
Maven Regulatory Solutions
Maven Regulatory Solutions is an international regulatory consultancy offering CER writing within a broader medical writing and regulatory affairs practice—with offices in the UK, US, and India serving medical device, pharma, and life sciences clients.
Cross-functional expertise across medical devices, pharmaceuticals, and biologics gives Maven an edge on CERs for combination products or devices with drug components—a scenario where single-domain consultancies often struggle.
| Attribute | Details |
|---|---|
| Key Services | CER writing, clinical study reports, regulatory medical writing, EU MDR consulting, QMS compliance |
| Regulatory Frameworks Covered | EU MDR, EU IVDR, US FDA, ICH guidelines |
| Notable Strength | Cross-sector capability (device + pharma + biologics); suited for combination product CER writing |
Regulatory Compliance Associates (RCA)
Regulatory Compliance Associates is a North American regulatory consulting firm with deep expertise in FDA regulatory strategy and documentation, offering CER writing and clinical evaluation support for manufacturers navigating both US and European markets.
Its strength lies in aligning CER-level clinical evidence with 510(k) and PMA requirements simultaneously. US manufacturers pursuing EU market access alongside domestic clearance get a streamlined path rather than two parallel documentation tracks.
| Attribute | Details |
|---|---|
| Key Services | CER writing, FDA 510(k)/PMA submissions, EU MDR consulting, regulatory strategy, quality systems |
| Regulatory Frameworks Covered | US FDA, EU MDR, ISO 13485 |
| Notable Strength | Dual FDA + EU MDR CER strategy; strong fit for US manufacturers entering the EU market |
Qserve Group
Qserve Group is a European medical device regulatory consulting firm specializing in EU MDR and IVDR compliance, offering CER writing alongside notified body liaison services, clinical investigations, and technical file remediation.
Deep notified body relationships across Europe allow Qserve to shape CER writing strategies around specific NB review patterns—reducing query rounds and rework cycles that add months to certification timelines.
| Attribute | Details |
|---|---|
| Key Services | CER/CEP writing, EU MDR consulting, notified body liaison, PMCF, technical file remediation |
| Regulatory Frameworks Covered | EU MDR, EU IVDR, MEDDEV guidelines |
| Notable Strength | Deep notified body network in Europe; CER strategies tailored to specific NB query patterns |
How We Chose the Best CER Writing Services
Each provider on this list was evaluated against six objective criteria — not on marketing claims or self-reported testimonials:
- Regulatory credential depth across EU MDR, FDA, and ISO frameworks
- Scientific writing expertise demonstrated through verifiable outputs
- Device type coverage (Class II/III, IVD, SaMD, implantables)
- Global market reach and notified body familiarity
- Pricing and timeline transparency
- Measurable outcomes such as audit clearance rates or NB approval records
Common mistakes manufacturers make when selecting a CER writing service:
- Prioritizing the lowest quote without accounting for post-submission query costs
- Accepting generic writer bios rather than confirming MEDDEV 2.7/1 rev 4 credentials
- Hiring generalist writers with no device-type-specific clinical or regulatory experience
- Skipping post-submission support, which often leads to expensive NB resubmissions
A MedTech Intelligence analysis of CER deficiencies found the most common failures include insufficient clinical data for legacy devices, inconsistent technical files, non-systematic literature reviews, and weak PMCF planning — all preventable with the right provider.
The providers listed span full-service CRO partnerships and focused regulatory boutiques. Your best fit depends on device complexity, target markets, and how much internal regulatory capacity your team already has.
Conclusion
Choosing the right CER writing service is not a commodity procurement decision—the quality of clinical evidence documentation directly determines how quickly and successfully a device reaches (and stays in) its target markets.
When evaluating providers, look beyond cost and turnaround speed. The factors that actually predict CER quality include:
- Credentials and clinical background of assigned writers
- Regulatory framework coverage (EU MDR, FDA, MHRA, Health Canada)
- Post-submission support and response to auditor queries
- Capacity to handle PMCF and PMS documentation as clinical evidence evolves
Elexes brings 50+ years of collective regulatory experience, a 90% audit clearance rate, and CER writing coverage across EU MDR, FDA, MHRA, and Health Canada. Reach out to discuss your CER project and connect with an expert matched to your device type and target market.
Frequently Asked Questions
What is a CER (clinical evaluation report) writer?
A CER writer is a qualified professional—typically with a medical, scientific, or regulatory background—who collects, appraises, and synthesizes clinical data from literature and post-market sources into a structured report. That report must demonstrate a device's safety and performance in line with EU MDR and equivalent regulations.
Who can write a clinical evaluation report?
Per EU MDR and MEDDEV 2.7/1 rev 4, a CER must be written or reviewed by qualified clinical evaluators with documented expertise in research methodology, medical writing, and the relevant clinical field. That person can be in-house staff, a specialist consultant, or a CRO—provided their qualifications are formally documented.
How long does it take to write a clinical evaluation report?
Timelines vary by device complexity, class, and data availability. A straightforward Class I or IIa device CER may take 4–8 weeks, while complex Class III devices or those requiring extensive systematic literature reviews can take 3–6 months. AI-assisted services can shorten timelines for less complex devices.
What is the difference between a CEP and a CER?
A Clinical Evaluation Plan (CEP) is the prospective document outlining the scope, methodology, and criteria for a clinical evaluation, while the Clinical Evaluation Report (CER) is the completed output documenting the findings. Under EU MDR Annex XIV, EU MDR requires both documents and mandates they be maintained throughout the device lifecycle.
How much does CER writing typically cost?
Costs vary widely based on device class, complexity, and provider type—ranging from several thousand dollars for straightforward Class I devices to tens of thousands for complex Class III implants. Fixed-price engagements are generally preferable to hourly billing to avoid scope creep.
Do I need a CER for FDA submissions?
The FDA does not formally require a CER in its EU MDR format, but does require clinical evidence in 510(k), De Novo, and PMA submissions. Many manufacturers leverage CER-style clinical data summaries to support both FDA and EU submissions simultaneously, improving efficiency for dual-market strategies.
